Studying the impact of presence of point mutation, insertion mutation and additional chromosomal abnormalities in chronic myeloid leukemia patients treated with imatinib mesylate in the State of Qatar-Reference-Cited by-同舟云学术

Studying the impact of presence of point mutation, insertion mutation and additional chromosomal abnormalities in chronic myeloid leukemia patients treated with imatinib mesylate in the State of Qatar

Published:2014-03-01 Issue:1 Volume:2014 Page:
ISSN:2223-506X
Container-title:QScience Connect
language:en
Short-container-title:

Author:

Al-Dewik Nader I¹²,Jewell Andrew P²³,Yassin Mohammed A¹,El-Ayoubi Hanadi R¹,Morsi Hisham M²³

Affiliation:

1. 1National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar

2. 2Faculty of Health and Social Care Sciences, Kingston University and St George's University of London, United Kingdom

3. 3Medical Research Centre, HMC, Doha, Qatar

Publisher

Hamad bin Khalifa University Press (HBKU Press)

Subject

General Medicine

Reference54 articles.

1. The molecular biology of chronic myeloid leukemia;Blood,2000

2. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics;Ann Intern Med,2003

3. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia;Cancer Res,2000

4. Chronic myelogenous leukemia: mechanisms underlying disease progression;Leukemia,2002

5. The biology of CML blast crisis;Blood,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies;Hematology;2023-04-20

2. Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients;Scientific Reports;2021-04-23

3. Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase;Medicine: Case Reports and Study Protocols;2021-02

4. Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar;Molecular Genetics & Genomic Medicine;2020-07-23

5. Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?;Clinical Medicine Insights: Oncology;2016-01